Global Cord Blood Stem Cell Storage Service Market Growth (Status and Outlook) 2024-2030

Global Cord Blood Stem Cell Storage Service Market Growth (Status and Outlook) 2024-2030

Cord blood stem cell storage means that the stem cell bank that saves cord blood for future use is called cord blood hematopoietic stem cell bank (CORD BLOOD BANK), or umbilical cord blood bank for short, which is also known as LIFE BANK internationally. It consists of public banks and family banks (autologous banks). In order to facilitate storage and clinical application, cord blood is separated and prepared by removing red blood cells and plasma as much as possible, and its nucleated cell components are enriched.



The global Cord Blood Stem Cell Storage Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Cord Blood Stem Cell Storage Service Industry Forecast” looks at past sales and reviews total world Cord Blood Stem Cell Storage Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Cord Blood Stem Cell Storage Service sales for 2023 through 2029. With Cord Blood Stem Cell Storage Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cord Blood Stem Cell Storage Service industry.

This Insight Report provides a comprehensive analysis of the global Cord Blood Stem Cell Storage Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cord Blood Stem Cell Storage Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cord Blood Stem Cell Storage Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cord Blood Stem Cell Storage Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cord Blood Stem Cell Storage Service.

United States market for Cord Blood Stem Cell Storage Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Cord Blood Stem Cell Storage Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Cord Blood Stem Cell Storage Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Cord Blood Stem Cell Storage Service players cover China Cord Blood Corporation, CSG-BIO, Cryo-Cell International, ViaCord (PerkinElmer), StemCell Institute Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Cord Blood Stem Cell Storage Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Cord Blood
Cord Tissue

Segmentation by Application:
Medical Therapy
Regenerative Medicine
Clinical Research
Individual Health Care
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Cord Blood
Cord Tissue

Segmentation by Application:
Medical Therapy
Regenerative Medicine
Clinical Research
Individual Health Care
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
China Cord Blood Corporation
CSG-BIO
Cryo-Cell International
ViaCord (PerkinElmer)
StemCell Institute Inc.
StemCyte
CBR Systems, Inc.
BrainStorm Cell Therapeutics
Cryoviva
Medipost
LifeCell International
Cordlife Group Limited
Cordvida
Smart Cells International Ltd.
Vita 34 AG
BGI Genomics
Sanpower Group Co., Ltd.

Please note: The report will take approximately 2 business days to prepare and deliver.